Forty-eight clinical-operations contractors stood up for an FDA submission window.
There was no version of this where we could be late or sloppy. They stood up a compliant team on the clock, and we kept a lot of them.
The outcome, in numbers.
The situation
The submission window was immovable and the work was regulated: the centre needed 48 clinical-operations professionals with the right qualifications, on the ground and productive, inside five months. Miss the ramp and the window closes.
Contract clinical talent at that specialisation is scarce, and a bad hire in a regulated workflow isn’t just slow — it’s a compliance risk.
What we did
We staffed for the deadline and the regulation together. Qualification and compliance screening were built into the front of the funnel, not bolted on at the end, so every candidate reaching the client was already cleared for the regulated work.
We sequenced the intake around the submission timeline so the team ramped in the order the project needed people, not all at once.
- 01 Compliance and qualification screening built into the front of the pipeline.
- 02 An intake sequenced to the submission timeline, role-critical functions first.
- 03 A bench of pre-vetted backups to absorb any late drop-outs without slippage.
- 04 A conversion path defined up front for the contractors worth keeping.
The outcome
All 48 were in seat and productive inside the five-month window, and the submission timeline held. The compliance-first screening meant no rework in a workflow where rework is a regulatory problem.
When the project closed, a meaningful share of the contractors converted to full-time — the engagement doubled as a low-risk, extended evaluation of talent the biotech went on to keep.
If a case like this looks like your problem, that's usually a sign.
Send us a brief or just describe what you're dealing with. We'll come back with one observation — even if we don't end up working together.